We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current KNRSF market cap is 43.33k. The company's latest EPS is USD 21.1365 and P/E is 0.51.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.5B | 4.21B | 3.73B | 3.9B | 4.24B |
| Operating Income | 991.2M | 1.9B | 463.6M | 558.2M | 801.4M |
| Net Income | 718.6M | 1.34B | 221.2M | -604.4M | 416.3M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 9.08B | 10.93B | 10.43B | 10.4B | 10.54B |
| Total Liabilities | 3.74B | 4.27B | 3.78B | 4.51B | 4.36B |
| Total Equity | 5.33B | 6.66B | 6.65B | 5.88B | 6.19B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.22B | 1.96B | 1.14B | 1.05B | 1.65B |
| Investing | -1.03B | -1.25B | -1.19B | -1.6B | -1.17B |
| Financing | 25.1M | -67.7M | -623.2M | 437.5M | -549M |
| Market Cap | 43.33k |
| Price to Earnings Ratio | 0.51 |
| Price to Sales Ratio | 0.05 |
| Price to Cash Ratio | 0.6 |
| Price to Book Ratio | 0.03 |
| Dividend Yield | - |
| Shares Outstanding | 19.7M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Kinarus Therapeutics Holding SA (GM) |
| Address |
25 york street, 17th floor toronto, ontario M5J 2V5 |
| Website | https://www.kinross.com |
| Industry | gold ores (1041) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
